ProSpec Tany Technogene
Rehovot, Israel· Est.
ProSpec provides cost‑effective, high‑quality recombinant proteins and technology licenses to accelerate life‑science research worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
ProSpec provides cost‑effective, high‑quality recombinant proteins and technology licenses to accelerate life‑science research worldwide.
OncologyImmunologyNeuroscienceEndocrinologyStem Cell ResearchRegenerative Medicine
Technology Platform
Proprietary bacterial expression and refolding pipeline delivering high‑yield, ultra‑pure recombinant proteins with rapid 4‑5 day batch cycles.
Opportunities
Expansion of technology‑license services and entry into GMP‑compliant production could open new therapeutic‑development markets.
Risk Factors
Intense competition from larger reagent suppliers and reliance on non‑GMP facilities may limit uptake for clinical‑grade applications.
Competitive Landscape
Competes with R&D Systems, Thermo Fisher, and Sino‑Biological; differentiates through cost‑effective bacterial production and customized refolding expertise.